BROOKS

Brooks Labs: Update on Steriscience–OneSource Amalgamation Scheme • 🔄 Merger Scheme Update: Update on amalgamation involving Steriscience Specialties, Brooks Steriscience, Strides Pharma Services and OneSource Specialty Pharma. • ✅ Exchange Clearance: No-Objection / No Adverse Observation letters received from BSE and NSE for the proposed scheme. • ⏳ Further Internal Review: Board of Brooks Steriscience (JV/Associate) to undertake additional review before filing with NCLT. • 📅 Approval Window: Scheme review expected to be completed within the 6-month validity period granted by exchanges. 🟡 Impact: Neutral Regulatory observations cleared, but final merger execution still pending further review and NCLT filing.